Ameriprise
IBDN

Ameriprise’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Ameriprise’s Portfolio IBDN Stock Details IBDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-244,321
Closed -$6.12M – 4133
2022
Q3 		$6.12M Sell
244,321
-165,756
-40% -$4.14M ﹤0.01% 2069
2022
Q2 		$10.3M Sell
410,077
-255,644
-38% -$6.4M ﹤0.01% 1728
2022
Q1 		$16.7M Sell
665,721
-119,183
-15% -$2.99M ﹤0.01% 1497
2021
Q4 		$19.7M Buy
784,904
+250,106
+47% +$6.31M 0.01% 1416
2021
Q3 		$13.5M Buy
534,798
+27,097
+5% +$687K ﹤0.01% 1589
2021
Q2 		$12.9M Buy
507,701
+25,165
+5% +$640K ﹤0.01% 1711
2021
Q1 		$12.3M Buy
482,536
+44,665
+10% +$1.14M ﹤0.01% 1711
2020
Q4 		$11.2M Sell
437,871
-94,291
-18% -$2.41M ﹤0.01% 1670
2020
Q3 		$13.6M Sell
532,162
-214,916
-29% -$5.51M 0.01% 1333
2020
Q2 		$20.6M Buy
747,078
+442,000
+145% +$11.2M 0.01% 1036
2020
Q1 		$7.56M Buy
305,078
+129,609
+74% +$3.25M ﹤0.01% 1598
2019
Q4 		$4.46M Buy
175,469
+25,771
+17% +$652K ﹤0.01% 2304
2019
Q3 		$3.79M Buy
149,698
+11,443
+8% +$289K ﹤0.01% 2355
2019
Q2 		$3.49M Buy
138,255
+18,122
+15% +$452K ﹤0.01% 2448
2019
Q1 		$2.98M Buy
120,133
+22,927
+24% +$564K ﹤0.01% 2541
2018
Q4 		$2.35M Buy
97,206
+13,352
+16% +$323K ﹤0.01% 2582
2018
Q3 		$2.04M Buy
83,854
+5,767
+7% +$140K ﹤0.01% 2809
2018
Q2 		$1.9M Buy
78,087
+19,967
+34% +$486K ﹤0.01% 2756
2018
Q1 		$1.43M Buy
58,120
+18,307
+46% +$451K ﹤0.01% 2821
2017
Q4 		$995K Buy
39,813
+20,629
+108% +$517K ﹤0.01% 2973
2017
Q3 		$485K Buy
19,184
+6,954
+57% +$176K ﹤0.01% 3234
2017
Q2 		$308K Buy
12,230
+2,205
+22% +$55.4K ﹤0.01% 3410
2017
Q1 		$250K Buy
+10,025
New +$249K ﹤0.01% 3410

Other funds holding IBDN

OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ameriprise's IBDN Position: Q4 2022 in Review

Ameriprise sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2022, closing a stake of 244,321 shares — an estimated $6.12M sold.

Ameriprise first reported a position in IBDN in Q1 2017 and held it in 23 quarters. The position peaked at $20.6M in Q2 2020. 2 funds tracked by Wall St. Rank hold IBDN as of Q4 2022.

  • Ameriprise reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Ameriprise sold 244,321 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2022, an estimated $6.12M.
  • Ameriprise first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q1 2017 and held it in 23 quarters.
  • Ameriprise's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $20.6M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2022.

Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.